Press Release

Depixus in the news

We regularly participate in the world’s leading conferences on tools and technologies for biomolecular analysis and therapeutics. Look out for our presentations and come and say hello to learn more about MAGNA™ and its transformative potential for life sciences research and drug development.

Depixus unveils MAGNA One: World’s first laboratory instrument for analyzing individual biomolecular interactions at scale

30th September 2024

Paris, France – Depixus, a pioneer in single molecule interactomics, is excited to announce the launch of MAGNA One, the world’s first consumer laboratory instrument for exploring individual biomolecular interactions at scale.

Read More

New study demonstrates power of Depixus’ scalable single molecule interactomics platform to accelerate RNA-targeted drug development

25th September 2024

Paris, France – A new research study published in Nature Communications highlights how Depixus’ scalable single molecule technology can provide detailed mechanistic insights into RNA-ligand binding, supporting the development of novel therapeutics.

Read More

New study highlights utility of Depixus’ single molecule interactomics technology to explore compounds targeting expanded RNA repeats

09th September 2024

We’ve collaborated with Professor Matthew Disney at the Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Florida, US, to use our scalable magnetic force spectroscopy (MFS) single molecule interactomics platform to explore compounds targeting an RNA repeat expansion in neurological disease.

Read More

View Older News